Quest International Enhances World-Class Logistics Services by Doubling Its Warehousing Capacity
IRVINE, CA / ACCESSWIRE / February 20, 2024 / Quest International, the global aftermarket service support partner for Healthcare and...
Day: February 20, 2024
Florence Healthcare and Slope Unite Forces to Address Site Technology Ecosystem Demand
Two Global Leaders in Site Enablement Technology Respond to Research Site Demand for End-to-End Solutions to Increase Efficiencies Across All...
Canopus Biopharma Inc. (OTC: PINK CBIA) dba Blue Heaven Coffee Inc. Announces Inaugural For-Profit Programmatic Advertising Campaign.
LAS VEGAS, NV / ACCESSWIRE / February 20, 2024 / Canopus Biopharma Inc. (OTC PINK:CBIA) dba Blue Heaven Coffee Inc....
Organon Launches U.S. Grant Programs and Listening Tour as Part of “Her Plan Is Her Power,” Reaching High-Need Communities To Help Reduce Unplanned Pregnancies
U.S. grant programs include: Funding for select community health clinics in contraceptive deserts in Texas, Ohio and Georgia and product...
Yunu Emerges as Industry Leader to Address the Way Imaging Data Impacts Breakthrough Therapy Development
Fast-growing innovator brings first-of-its-kind imaging ecosystem to clinical trialsCARY, NC / ACCESSWIRE / February 20, 2024 / With the rapid...
Biolase Announces First Quarter 2024 Webinar Series ‘Lets Talk Dental’
LAKE FOREST, CA / ACCESSWIRE / February 20, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, remains...
TerrAscend to Host Fourth Quarter and Full Year 2023 Earnings Conference Call
TORONTO, Feb. 20, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North...
PharmAla Data to be Published in ACS Chemical Neuroscience
Scientific Journal Article follows notable IP updates, including publication of key PCT Patent Application, presentation at International Society for Research...
Fractyl Health Appoints Samuel Conaway to Its Board of Directors, Bolstering New Product Commercial Expertise During Revita® Pivotal Clinical Trials
LEXINGTON, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (“Fractyl Health” or the “Company”), a metabolic...
Neuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call
MALVERN, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing,...
Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
WATERTOWN, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery,...
Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® to Maine Dental Group, a Premier Group Practice with 21 Locations Across the Northeast
ROSELAND, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments...
Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors
CAMBRIDGE, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science...
Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan
Amendment to existing exclusive license agreement with Orion Corporation expands Tenax’s territory rights from North America, to the entire worldExpanded...
Veru Announces New Scientific Advisory Board for its Enobosarm Program for High Quality Weight Loss
MIAMI, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing...
Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Feb. 20, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) (“Lifeward” or the...
Capricor Therapeutics Announces Manufacturing Scale-Up of CAP-1002 Production at New San Diego Facility as it Continues Plans Toward Commercialization
-Cohort B of HOPE-3, Phase 3 Clinical Trial Expected to Complete Enrollment in Second Quarter 2024- SAN DIEGO, Feb. 20,...
Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board
Board expertise encompasses oligonucleotide research, development, manufacturing and commercialization to support development of ECO Synthesis™ manufacturing platform Masad Damha, PhD...
Lipella Pharmaceuticals to Present at PropThink Digital Investor Conference
Chief Medical Officer Dr. Michael Chancellor will discuss hemorrhagic cystitis and the company’s lead candidate, LP-10PITTSBURGH, Feb. 20, 2024 (GLOBE...
MIMEDX to Present at TD Cowen 44th Annual Health Care Conference
MARIETTA, Ga., Feb. 20, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that...